Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Therapeutics (MT) and Population Studies Research Program (PS Research Program).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Pancreatic Cancer Breakthrough

FOX 2 A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in pre-clinical studies for treat...

Read More

Strengthening Clinical Trial Communication: Karmanos and McLaren Launch First Joint Oncology, Non-Oncology Study

The Karmanos Cancer Network and the McLaren Center for Research and Innovation (MCRI) have officially partnered on their first collaborative resea...

Read More

IN THE NEWS: What You May Not Know About HPV and Cervical Cancer Screening

WWJ The human papillomavirus (HPV) causes many cancers – one of those is cervical cancer. Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and ...

Read More
News

WWJ | What You May Not Know About HPV and Cervical Cancer Screening

Listen Now

94.7 WCSX | Cervical Cancer Awareness Month

Listen Now

WSGW | Risks of Pancreatic Cancer

Listen Now